Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.34 |
| ▸ | EPAS1 | Q99814 | 3/20 | 0.34 |
| ▸ | UGCG | Q16739 | 1/20 | 0.34 |
| ▸ | PDE5A | O76074 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31682177 | 0.88 | UGCG (0.34) | ALDH1A1MAPTUGCGMEN1KMT2A | |
| SCHEMBL31682193 | 0.85 | SOS1 (0.40) | GAAL3MBTL1MAPTUGCGCYP2A6 | |
| SCHEMBL31682201 | 0.83 | AMY1A (0.35) | ALDH1A1GAAL3MBTL1MAPTUGCG | |
| SCHEMBL31682174 | 0.82 | HRH1 (0.48) | ALDH1A1GAAL3MBTL1MAPTUGCG | |
| SCHEMBL31682185 | 0.82 | ALDH1A1 (0.46) | ALDH1A1KDM4EGAAL3MBTL1MAPT | |
| SCHEMBL31682190 | 0.82 | LDHA (0.40) | ALDH1A1KDM4EL3MBTL1SMN1; SMN2NPC1 | |
| SCHEMBL31682173 | 0.82 | AMY1A (0.39) | ALDH1A1L3MBTL1 | |
| SCHEMBL31682175 | 0.82 | MAPT (0.42) | ALDH1A1KDM4EL3MBTL1MAPTMEN1 | |
| SCHEMBL31682198 | 0.81 | USP2 (0.36) | ALDH1A1GAAKMT2ALMNAHPGD | |
| SCHEMBL31682178 | 0.81 | UGCG (0.34) | ALDH1A1KDM4EGAAL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289808-A1 | NOVEL CARBOXAMIDE REDOX DERIVATIVE OF INHIBITING BET PROTEIN AND COMPOSITION FOR PREVENTING AND TREATING OPHTHALMIC DISEASES USING THE SAME | BenoBio Co., Ltd (KR) | 2025-09-18 | — | — | US | disclosed |
| EP-4613329-A1 | COMPOUND FOR INHIBITING BRD PROTEIN | Benobio Co., Ltd. (KR) | 2025-09-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289808-A1 | NOVEL CARBOXAMIDE REDOX DERIVATIVE OF INHIBITING BET PROTEIN AND COMPOSITION FOR PREVENTING AND TREATING OPHTHALMIC DISEASES USING THE SAME | BET1, BRD4, BRD3 | ALDH1A1 3210/4885KDM4E 87/4885GAA 4124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.